CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 73 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $182,345 | +48.1% | 155,850 | 0.0% | 0.05% | +45.5% |
| Q4 2022 | $123,122 | -35.2% | 155,850 | -0.6% | 0.03% | -37.7% |
| Q3 2022 | $190,000 | +31.9% | 156,850 | 0.0% | 0.05% | +51.4% |
| Q2 2022 | $144,000 | -48.8% | 156,850 | 0.0% | 0.04% | -39.7% |
| Q1 2022 | $281,000 | -11.6% | 156,850 | 0.0% | 0.06% | -18.3% |
| Q3 2021 | $318,000 | -41.8% | 156,850 | 0.0% | 0.07% | -45.4% |
| Q2 2021 | $546,000 | – | 156,850 | +46.8% | 0.13% | – |
| Q1 2021 | $0 | -100.0% | 106,850 | +0.9% | 0.00% | -100.0% |
| Q4 2020 | $107,000 | – | 105,850 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
| Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
| Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
| Freed Investment Group | 14,600 | $26,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
| LMR Partners LLP | 63,950 | $114,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
| Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |